采用siRNA和Simvastatin作为"Nanoscavenger"用于协同性动脉样硬化治疗的Zwitterionic超分子纳米组件
Weihong Ji1, Weichen Shao1, Xing Ye1
1Institute of Biomaterials and Tissue Engineering, Fujian Provincial Key Laboratory of Biochemical Technology, College of Chemical Engineering, Huaqiao University, Xiamen, Fujian, 361021, P. R. China.
Small (Weinheim an der Bergstrasse, Germany)
|October 7, 2025
概括
新的纳米吸收剂PCDSC-S2P通过向胆固醇,脂质和炎症来有效减少和稳定动脉样硬化斑块. 这种新的输送系统在治疗动脉样硬化方面表现有前途.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 心血管研究研究心血管研究
背景情况:
- 动脉样硬化斑块含有多余的胆固醇,受损的血细胞增生和炎症因素,限制了常规药物的疗效.
- 针对复杂的斑块病理生理学需要创新的治疗策略.
研究的目的:
- 开发zwitterionic超分子纳米组件 (PCDSC-S2P) 作为用于减少和稳定动脉样斑块的纳米清除剂.
- 评估胆固醇去除,降低脂质和增强血细胞分裂的协同治疗效果.
主要方法:
- 制造Zwitterionic多基 ((carboxybetaine) 修饰的β-cyclodextrin纳米组件封装simvastatin并吸收siCaMKIIγ.
- 通过向巨细胞的酸进行修改,以促进斑块的积累.
- 在非脂蛋白E缺乏的小鼠体内评估,食高脂肪饮食.
主要成果:
- PCDSC-S2P纳米组件通过清除胆固醇,通过simvastatin调解降低脂质,以及通过siCaMKIIγ增强的乙细胞分裂,表现出协同作用.
- 治疗调节了炎症性细胞因子的释放,并表现出抗炎活性.
- 在体内观察到显著减少斑块面积和改善斑块稳定性.
结论:
- PCDSC-S2P纳米组件作为动脉样硬化治疗的有效纳米吸收器.
- 该系统显示了开发用于心血管疾病的新型小干扰RNA配方的潜力.
- 这项研究突出了对复杂斑块病理的有希望的纳米输送策略.
更多相关视频
10:33Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes
Published on: July 23, 2016
11.1K
15:55Long-term Silencing of Intersectin-1s in Mouse Lungs by Repeated Delivery of a Specific siRNA via Cationic Liposomes. Evaluation of Knockdown Effects by Electron Microscopy
Published on: June 21, 2013
11.1K
相关概念视频
02:30siRNA - Small Interfering RNAs
18.4K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.4K
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:27Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
01:27Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
01:23RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K